Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-18

Clinical Trial Update: Soy Protein/Effexor Hormone Therapy for Prostate Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating soy protein combined with Effexor hormone therapy for hot flashes in prostate cancer patients was terminated, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Effexor (venlafaxine)
  • Soy protein (soy protein)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Hot Flashes, Prostate Cancer | Phase 3 | Status: TERMINATED | Results posted: 2017-05-18